Found: 28
Select item for more details and to access through your institution.
Dupilumab provides favourable long‐term safety and efficacy in children aged ≥ 6 to < 12 years with uncontrolled severe atopic dermatitis: results from an open‐label phase IIa study and subsequent phase III open‐label extension study
- Published in:
- British Journal of Dermatology, 2021, v. 184, n. 5, p. 857, doi. 10.1111/bjd.19460
- By:
- Publication type:
- Article
Ustekinumab for the treatment of moderate‐to‐severe plaque psoriasis in paediatric patients (≥ 6 to < 12 years of age): efficacy, safety, pharmacokinetic and biomarker results from the open‐label CADMUS Jr study.
- Published in:
- British Journal of Dermatology, 2020, v. 183, n. 4, p. 664, doi. 10.1111/bjd.19018
- By:
- Publication type:
- Article
Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials.
- Published in:
- British Journal of Dermatology, 2020, v. 183, n. 2, p. 242, doi. 10.1111/bjd.18898
- By:
- Publication type:
- Article
The impact of airborne pollution on atopic dermatitis: a literature review.
- Published in:
- British Journal of Dermatology, 2020, v. 183, n. 1, p. 16, doi. 10.1111/bjd.18781
- By:
- Publication type:
- Article
Topical therapy of atopic dermatitis with a focus on pimecrolimus.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2021, v. 35, n. 7, p. 1505, doi. 10.1111/jdv.17272
- By:
- Publication type:
- Article
A position paper on the management of itch and pain in atopic dermatitis from the International Society of Atopic Dermatitis (ISAD)/Oriented Patient‐Education Network in Dermatology (OPENED) task force.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2021, v. 35, n. 4, p. 787, doi. 10.1111/jdv.16916
- By:
- Publication type:
- Article
Safety and efficacy of topical, fixed‐dose combination calcipotriene (0.005%) and betamethasone (0.064% as dipropionate) gel in adolescent patients with scalp and body psoriasis: a phase II trial.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2020, v. 34, n. 5, p. 1098, doi. 10.1111/jdv.16077
- By:
- Publication type:
- Article
Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy – international eczema council survey and opinion.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2019, v. 33, n. 7, p. 1224, doi. 10.1111/jdv.15608
- By:
- Publication type:
- Article
Consensus guidelines in diagnosis and treatment of atopic dermatitis.
- Published in:
- Allergy, 2004, v. 59, p. 86, doi. 10.1111/j.1398-9995.2004.00569.x
- By:
- Publication type:
- Article
特应性湿疹的治疗 (TREAT) 登记工作组:比较 Dupilumab 与其他全身药物治疗中度至重度湿疹安全性的方法
- Published in:
- British Journal of Dermatology, 2020, v. 182, n. 6, p. e199, doi. 10.1111/bjd.19078
- By:
- Publication type:
- Article
TREatment of ATopic eczema (TREAT) Registry Taskforce: method for comparing the safety of dupilumab with other systemic therapies for moderate‐to‐severe eczema.
- Published in:
- British Journal of Dermatology, 2020, v. 182, n. 6, p. e187, doi. 10.1111/bjd.19066
- By:
- Publication type:
- Article
TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczema.
- Published in:
- British Journal of Dermatology, 2020, v. 182, n. 6, p. 1423, doi. 10.1111/bjd.18452
- By:
- Publication type:
- Article
一项关于 dupilumab 治疗湿疹青少年患者的研究.
- Published in:
- British Journal of Dermatology, 2020, v. 182, n. 1, p. e47, doi. 10.1111/bjd.18678
- By:
- Publication type:
- Article
A study of dupilumab in the treatment of adolescents with eczema.
- Published in:
- British Journal of Dermatology, 2020, v. 182, n. 1, p. e30, doi. 10.1111/bjd.18661
- By:
- Publication type:
- Article
Dupilumab in adolescents with uncontrolled moderate‐to‐severe atopic dermatitis: results from a phase IIa open‐label trial and subsequent phase III open‐label extension.
- Published in:
- British Journal of Dermatology, 2020, v. 182, n. 1, p. 85, doi. 10.1111/bjd.18476
- By:
- Publication type:
- Article
关于 AE 治疗研究注册核心数据集测量的共识.
- Published in:
- British Journal of Dermatology, 2019, v. 181, n. 3, p. e77, doi. 10.1111/bjd.18284
- By:
- Publication type:
- Article
Consensus on measurement of core dataset for AE treatment research registries.
- Published in:
- British Journal of Dermatology, 2019, v. 181, n. 3, p. e65, doi. 10.1111/bjd.18270
- By:
- Publication type:
- Article
TREatment of ATopic eczema (TREAT) Registry Taskforce: consensus on how and when to measure the core dataset for atopic eczema treatment research registries.
- Published in:
- British Journal of Dermatology, 2019, v. 181, n. 3, p. 492, doi. 10.1111/bjd.17715
- By:
- Publication type:
- Article
Use of an alternative method to evaluate erythema severity in a clinical trial: difference in vehicle response with evaluation of baseline and postdose photographs for effect of oxymetazoline cream 1·0% for persistent erythema of rosacea in a phase IV study
- Published in:
- British Journal of Dermatology, 2019, v. 180, n. 5, p. 1050, doi. 10.1111/bjd.17462
- By:
- Publication type:
- Article
AE 光疗和系统治疗登记数据库的 TREAT eDelphi 练习.
- Published in:
- British Journal of Dermatology, 2019, v. 180, n. 4, p. e139, doi. 10.1111/bjd.17681
- By:
- Publication type:
- Article
TREAT eDelphi exercise for AE photo‐ and systemic therapy registries.
- Published in:
- British Journal of Dermatology, 2019, v. 180, n. 4, p. e123, doi. 10.1111/bjd.17665
- By:
- Publication type:
- Article
TREatment of ATopic eczema (TREAT) Registry Taskforce: an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema photo‐ and systemic therapy registries.
- Published in:
- British Journal of Dermatology, 2019, v. 180, n. 4, p. 790, doi. 10.1111/bjd.16714
- By:
- Publication type:
- Article
Comparing the effect of bleach and water baths on skin barrier function in atopic dermatitis: a split-body randomized controlled trial.
- Published in:
- British Journal of Dermatology, 2016, v. 175, n. 1, p. 212, doi. 10.1111/bjd.14483
- By:
- Publication type:
- Article
Photodynamic therapy with methyl aminolaevulinate 80 mg g<sup>−1</sup> for severe facial acne vulgaris: a randomized vehicle-controlled study.
- Published in:
- British Journal of Dermatology, 2016, v. 174, n. 4, p. 770, doi. 10.1111/bjd.14345
- By:
- Publication type:
- Article
Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials ( HOME).
- Published in:
- British Journal of Dermatology, 2014, v. 171, n. 6, p. 1318, doi. 10.1111/bjd.13237
- By:
- Publication type:
- Article
CASE REPORT Disseminated linear calcinosis cutis associated with the Koebner phenomenon in an infant with congenital acute monocytic leukaemia.
- Published in:
- British Journal of Dermatology, 2004, v. 150, n. 4, p. 753, doi. 10.1111/j.0007-0963.2004.05895.x
- By:
- Publication type:
- Article
Epidemiology and Health Services Research Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1550 patients from the pimecrolimus cream 1% randomized controlled clinical trials programme.
- Published in:
- British Journal of Dermatology, 2004, v. 150, n. 1, p. 96, doi. 10.1111/j.1365-2133.2004.05696.x
- By:
- Publication type:
- Article
International Consensus Conference on Atopic Dermatitis II (ICCAD II*): clinical update and current treatment strategies.
- Published in:
- British Journal of Dermatology, 2003, v. 148, p. 3, doi. 10.1046/j.1365-2133.148.s63.1.x
- By:
- Publication type:
- Article